Drug information for XIGRIS

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
VIAL; INTRAVENOUS 20MG/VIAL Prescription   DROTRECOGIN ALFA (ACTIVATED) drotrecogin alfa activated LILLY 125029
2011-12-20 Other Important Information from FDA
2007-03-31 Letter
2007-03-31 Label
2005-08-31 Letter
2005-07-07 Label
2005-01-26 Letter
2005-01-26 Label
2004-03-30 Letter
2004-03-30 Label
2004-03-30 Review
VIAL; INTRAVENOUS 5MG/VIAL Prescription   DROTRECOGIN ALFA (ACTIVATED) drotrecogin alfa activated LILLY   "

Drug Adverse Effects information for XIGRIS

Role code Indications Reaction # Reports
PS SEPSIS DEATH 1
PS SEPSIS DISSEMINATED INTRAVASCULAR COAGULATION 1
PS SEPSIS GENERAL PHYSICAL HEALTH DETERIORATION 1
PS SEPSIS INTERNATIONAL NORMALISED RATIO INCREASED 1
PS SEPSIS MULTI-ORGAN FAILURE 1
PS SEPSIS MYOCARDIAL INFARCTION 1
PS SEPSIS PLATELET COUNT DECREASED 1
PS SEPSIS RENAL FAILURE 1
PS SEPSIS RESPIRATORY FAILURE 1
PS SEPSIS SEPSIS 1
PS SEPSIS SEPTIC SHOCK 1
PS SEPTIC SHOCK BRAIN DEATH 2
PS SEPTIC SHOCK BRAIN OEDEMA 2
PS SEPTIC SHOCK CEREBRAL HAEMORRHAGE 1
PS SEPTIC SHOCK DEATH 1
PS SEPTIC SHOCK HAEMORRHAGE INTRACRANIAL 1
PS SEPTIC SHOCK SEPTIC SHOCK 1
C ATRIAL FIBRILLATION CIRCULATORY COLLAPSE 1
C ATRIAL FIBRILLATION VENTRICULAR TACHYCARDIA 1
C SEPSIS CIRCULATORY COLLAPSE 1
C SEPSIS VENTRICULAR TACHYCARDIA 1
Ads by Google